PhotoCure ASA (OSL:PHO) Net Income From Continuing Operations : kr8.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is PhotoCure ASA Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. PhotoCure ASA's net income from continuing operations for the three months ended in Dec. 2024 was kr1.2 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was kr8.4 Mil.

PhotoCure ASA Net Income From Continuing Operations Historical Data

The historical data trend for PhotoCure ASA's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PhotoCure ASA Net Income From Continuing Operations Chart

PhotoCure ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

-33.23

-31.66

-71.13

9.74

8.39

PhotoCure ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Income From Continuing Operations	Get a 7-Day Free Trial															16.55	-4.01	16.16	-4.94	1.18

PhotoCure ASA Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr8.4 Mil.

PhotoCure ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PhotoCure ASA (OSL:PHO) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

PHCUF:USA PHOO:Sweden 0IMT:UK PHS:Germany

Address

Hoffsveien 4, Oslo, NOR, 0275

Website

https://www.photocure.com

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.